The first evidence of PNPLA3 being associated with NAFLD was revealed by a genome-wide association study (GWAS) of Hispanic, African American, and European American individuals in the Dallas Heart Study back in 2008 [12]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.